Hasten Biopharmaceutical buys asset rights for 14 branded products from Celltrion

In a significant move, CBC Group, Asia's largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its portfolio company, Hasten Biopharmaceutical, has successfully acquired ... Read More